上海：延伸商业健康保险服务领域，提升创新药械的可及性和可负担性

Core Viewpoint - The document outlines measures to promote the high-quality development of commercial health insurance, aiming to support innovation in the biopharmaceutical industry through enhanced collaboration and service extension [1] Group 1: Measures for Commercial Health Insurance - The measures emphasize extending the service areas of commercial health insurance [1] - There is a focus on promoting the synergy between commercial health insurance, medical services, medical insurance, and pharmaceuticals [1] - The initiative encourages collaboration between insurance institutions and entities in the health industry and biopharmaceutical sector [1] Group 2: Collaboration and Innovation - The document highlights the importance of leveraging the professional advantages of medical expense audits to participate in standardizing medical practices [1] - It explores mechanisms for collective procurement price negotiations for drugs, communication regarding new drug listings, and payment based on treatment efficacy [1] - The goal is to enhance the accessibility and affordability of innovative drugs and medical devices [1]